Immunohistochemical localization of prostate-specific antigen in ductal epithelium of male breast: Potential diagnostic pitfall in patients with gynecomastia

Applied Immunohistochemistry and Molecular Morphology

Volumn 8, Issue 2, 2000, Pages 158-161

  Gatalica, Zoran ^a,c   Norris, Brent A ^a   Kovatich, Albert J ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c John Sealy Hospital and John Sealy Annex   (United States)

Author keywords

Ductal epithelium; Gynecomastia; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; GYNECOMASTIA; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ACID PHOSPHATASE; ADOLESCENT; ADULT; AGED; ANDROGEN ANTAGONISTS; BREAST; BREAST NEOPLASMS, MALE; DIAGNOSIS, DIFFERENTIAL; EPITHELIUM; FEMALE; GYNECOMASTIA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0033867901     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200006000-00011     Document Type: Article

References (25)

1. Bland KI, Graves TA, Page DL. Gynecomastia. In: Bland KI, Copeland EM, eds. The breast. Philadelphia: WB Saunders, 1998: 153-89.
2. Petersen RO. Urologic pathology. Philadelphia: JB Lippincott, 1992:605-9.
3. Braunstein GD. Gynecomastia. N Engl J Med 1993;328:490-5.
4. Boccon-Gibod L, Fournier G, Bottet P, Marechal JM, Guiter J, Rischman P, Hubert J, Soret JY, Mangin P, Mallo C, Fraysse CE. Flutamide versus orchiectomy in the treatment of metastatic prostate carcinoma. Eur Urol 1997;32:391-5.
5. Narayan P, Trachtenberg J, Lepor H, Debruyne FMJ, Tewari A, Stone N, Das S, Jimenez-Cruz JF, Shearer R, Klimberg I, Schellhammer PF, Costello AJ. A dose response study of flutamide on benign prostatic hyperplasia: results of multicenter study. Urology 1996;47:497-504.
6. Salyer WR, Salyer DC. Metastases of prostatic carcinoma to the breast. J Urol 1973;109:671-5.
7. Green LK, Klima M. The use of immunohistochemistry in metastatic prostate adenocarcinoma to the breast. Hum Pathol 1991;22: 242-6.
8. Elgamal AAA, Ectors NL, Sunardh-Widyaputra SS, Van Poppel HP, Van Damme BJ, Baert LV. Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation. J Urol 1996:156;464-8.
9. Papotti M, Paties C, Peveri V, Moscuzza L, Bussolati G. Immunocytochemical detection of prostate-specific antigen (PSA) in skin adnexal and breast tissues and tumors. Basic Appl Histochem 1989;33:25-9.
10. Levanesque M, Hu H, D'Costa M, Diamandis EP. Prostate specific antigen expression by various tumors. J Clin Lab Anal 1995;9: 123-8.
11. Van Krieken JHJM. Prostate marker immunoreactivity in salivary gland neoplasms. Am J Surg Pathol 1993;17:410-4.
12. Yu H, Diamandis E and Sutherland DJA. Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 1994;27:75-9.
13. Diamandis EP, Yu H, Sutherland DJA. Detection of prostate specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 1994;32:301-10.
14. Gatalica Z. Immunohistochemical analysis of apocrine breast lesions. Pathol Res Pract 1997;193:753-8.
15. Harlow E, Lane D. Using antibodies. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1999:107.
16. Niewoehner CB, Nuttal FQ. Gynecomastia in hospitalized male patient. Am J Med 1984;77:633-8.
17. Thompson DF, Reading Carter J. Drug-induced gynecomastia. Pharmacotherapy 1993;13:37-45.
18. Staiman VR, Lowe FC. Tamoxifen for flutamide/finasteride-induced gynecomastia. Urology 1997;50:929-33.
19. Kumar PP, Good RR, Newland JR. Immunodiagnosis by prostatic acid phosphatase to differentiate primary male breast cancer from metastatic prostate carcinoma. J Natl Med Assoc 1986;78:782-6.
20. Fukutani K, Kawabe K, Matsuki K, Endo H, Mikata N, Yokoyama M. Breast metastases of prostatic carcinoma: immunohistochemical study. Urol Int 1987;42:395-7.
21. Howarth DJC, Aronson IB, Diamandis EP. Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues. Br J Cancer 1997;75:1646-51.
22. Monne M, Croce CM, Yu H, Diamandis EP. Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res 1994;54:6344-7.
23. Wilhelm MC, Langenburg SE, Wanebo HJ. Cancer of the male breast. In: Bland KI, Copeland EM, eds. The breast. Philadelphia: WB Saunders, 1998:1416-20.
24. Yu H, Diamandis EP, Monne M, Croce CM. Oral contraceptive-induced expression of prostate-specific antigen in the female breast. J Biol Chem 1995;270:6615-8.
25. Sauter ER, Babb J, Daly M, Engstrom PF, Ehya H, Malick J, Diamandis E. Prostate-specific antigen production in the female breast: association with progesterone. Cancer Epidemiol Biomark Prev 1998;7:315-20.